American heart journal Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Association of cardiovascular diseases with cognitive performance in older adults..  10-20. 2024
• Testing interventions to reduce clinical inertia in the treatment of hypertension: rationale and design of a pragmatic randomized controlled trial..  18-28. 2023
• Physician Assessment of Aortic Stenosis Severity, Quantitative Parameters, and Long-Term Outcomes: Results from the KP-VALVE Project..  32-47. 2023
• Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and design..  121-131. 2023
• Physician responses to apple watch-detected irregular rhythm alerts..  29-37. 2023
• Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning method..  124-140. 2023
• Clinical and Cost Implications of Deferred Testing in Low-risk Patients with Stable Chest Pain: A Simulation Using the PROMISE Trial..  124-126. 2023
• Physical Activity and Relationship to Physical Function, Quality of Life, and Cognitive Function in Older Patients with Acute Decompensated Heart Failure..  85-94. 2022
• Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis..  60-72. 2022
• Association of change in QRS duration with chronic heart failure outcomes..  77-80. 2022
• Corrigendum to "Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease" [Am Heart J (2021) 231:36-44]..  99-100. 2022
• Choice of Antihypertensive Agent in Isolated Systolic Hypertension and Isolated Diastolic Hypertension: A Secondary Analysis of the ALLHAT Trial..  30-34. 2022
• Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis..  101-114. 2022
• Preexisting frailty and outcomes in older patients with acute myocardial infarction..  34-44. 2022
• The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial..  136-148. 2021
• Achievement and quality measure attainment in patients hospitalized with atrial fibrillation: Results from The Get With The Guidelines - Atrial Fibrillation (GWTG-AFIB) registry..  90-99. 2021
• The influence of heart failure on clinical and economic outcomes among older adults ≥75 years of age with acute myocardial infarction..  65-73. 2021
• Associations between neighborhood socioeconomic cluster and hypertension, diabetes, myocardial infarction, and coronary artery disease within a cohort of cardiac catheterization patients..  201-209. 2021
• Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018..  103-109. 2021
• Patient characteristics, care patterns, and outcomes of atrial fibrillation associated hospitalizations in patients with chronic kidney disease and end-stage renal disease..  45-60. 2021
• Does study subject diversity influence cardiology research site performance?: Insights from 2 U.S. National Coronary Stent Registries..  37-48. 2021
• Differences between patients with cardiovascular disease and cancer referred for palliative care..  5-9. 2020
• Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease..  36-44. 2020
• Cardiovascular implications of idiopathic pulmonary fibrosis: A way forward together?.  69-74. 2020
• Sarcopenia and health-related quality of life in older adults after transcatheter aortic valve replacement..  171-181. 2020
• Specificity of administrative coding for older adults with acute heart failure hospitalizations..  1-2. 2020
• A multicenter trial of a shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE-ICD rationale, design, Medicare changes, and pilot data..  161-173. 2020
• Association of plasma-soluble ST2 and galectin-3 with cardiovascular events and mortality following cardiac surgery..  253-263. 2019
• Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials..  110-122. 2019
• Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry..  113-124. 2019
• Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study..  91-96. 2019
• Trends in cardiorespiratory fitness: The evolution of exercise treadmill testing at a single Academic Medical Center from 1970 to 2012..  88-97. 2019
• Admission diagnoses among patients with heart failure: Variation by ACO performance on a measure of risk-standardized acute admission rates..  19-26. 2018
• Validation of the Seattle angina questionnaire in women with ischemic heart disease..  117-123. 2018
• The effect of Aliskiren on exercise capacity in older patients with heart failure and preserved ejection fraction: A randomized, placebo-controlled, double-blind trial..  164-167. 2018
• Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial..  1-8. 2017
• Response to the letter to the editor..  -. 2017
• Corrigendum to 'Association of Standard Clinical and Laboratory Variables with Red Blood Cell Distribution Width (RDW)'[Am. Heart J. (2016) 22-28]..  -. 2017
• Impact of AHA's 2007 guideline change on incidence of infective endocarditis in infants and children..  110-119. 2017
• Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial..  130-138. 2017
• Cardiac rehabilitation in heart failure with reduced ejection fraction: A "take it or leave it" intervention..  127-129. 2017
• Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale..  130-139. 2016
• Socioeconomic and partner status in chronic heart failure: Relationship to exercise capacity, quality of life, and clinical outcomes..  54-61. 2016
• Exploring cognitive bias in destination therapy left ventricular assist device decision making: A retrospective qualitative framework analysis..  64-73. 2016
• Impact of moderate physical activity on the longitudinal trajectory of a cardiac specific biomarker of injury: Results from a randomized pilot study of exercise intervention..  151-6. 2016
• The association of left ventricular ejection fraction with clinical outcomes after myocardial infarction: Findings from the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get With the Guidelines (GWTG) Medicare-linked database..  65-73. 2016
• Treatment of anxiety in patients with coronary heart disease: Rationale and design of the UNderstanding the benefits of exercise and escitalopram in anxious patients WIth coroNary heart Disease (UNWIND) randomized clinical trial..  53-62. 2016
• Association of standard clinical and laboratory variables with red blood cell distribution width..  22-8. 2016
• Hospital variation in admission to intensive care units for patients with acute myocardial infarction..  170:1161-9. 2015
• Unique challenges of hospice for patients with heart failure: A qualitative study of hospice clinicians..  170:524-30.e3. 2015
• Genome-wide association study of new-onset atrial fibrillation after coronary artery bypass grafting surgery..  170:580-90.e28. 2015
• National assessment of early β-blocker therapy in patients with acute myocardial infarction in China, 2001-2011: The China Patient-centered Evaluative Assessment of Cardiac Events (PEACE)-Retrospective AMI Study..  170:506-15.e1. 2015
• New-onset versus prior history of atrial fibrillation: Outcomes from the AFFIRM trial..  170:156-63, 163.e1. 2015
• Authorship in a multicenter clinical trial: The Heart Failure-A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) Authorship and Publication (HAP) scoring system results..  169:457-63.e6. 2015
• Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization: design and rationale for the Geriatric OUt of hospital Randomized MEal Trial in Heart Failure (GOURMET-HF)..  169:342-348.e4. 2015
• Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: the Cooper Center Longitudinal Study..  169:290-297.e1. 2014
• Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study..  168:931-9.e2. 2014
• Physical activity and resting pulse rate in older adults: findings from a randomized controlled trial..  168:597-604. 2014
• National trends in stroke after acute myocardial infarction among Medicare patients in the United States: 1999 to 2010..  169:78-85.e4. 2014
• Impact of the ENHANCE trial on the use of ezetimibe in the United States and Canada..  167:683-9. 2014
• Obesity and sleep apnea are independently associated with adverse left ventricular remodeling and clinical outcome in patients with atrial fibrillation and preserved ventricular function..  167:620-6. 2014
• The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure..  167:193-202.e1. 2013
• Racial differences in antilipemic use and lipid control in high-risk older adults: post-Medicare Part D..  166:792-7. 2013
• Race, exercise training, and outcomes in chronic heart failure: findings from Heart Failure - a Controlled Trial Investigating Outcomes in Exercise TraiNing (HF-ACTION)..  166:488-95. 2013
• Risk stratification for death and all-cause hospitalization in heart failure clinic outpatients..  166:895-903.e1. 2013
• Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION)..  165:193-9. 2012
• A gender-specific blood-based gene expression score for assessing obstructive coronary artery disease in nondiabetic patients: results of the Personalized Risk Evaluation and Diagnosis in the Coronary Tree (PREDICT) trial..  164:320-6. 2012
• Exercise effects on lipids in persons with varying dietary patterns-does diet matter if they exercise? Responses in Studies of a Targeted Risk Reduction Intervention through Defined Exercise I..  164:117-24. 2012
• Racial differences in hospice use and patterns of care after enrollment in hospice among Medicare beneficiaries with heart failure..  163:987-993.e3. 2012
• Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease..  163:844-850.e1. 2012
• Physical function and independence 1 year after myocardial infarction: observations from the Translational Research Investigating Underlying disparities in recovery from acute Myocardial infarction: Patients' Health status registry..  163:790-6. 2012
• Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis..  163:354-64. 2012
• Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study..  163:274-9. 2012
• Relationship of technetium-99m tetrofosmin-gated rest single-photon emission computed tomography myocardial perfusion imaging to death and hospitalization in heart failure patients: results from the nuclear ancillary study of the HF-ACTION trial..  161:1038-45. 2011
• Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA)..  161:639-645.e1. 2011
• Who is missing from the measures? Trends in the proportion and treatment of patients potentially excluded from publicly reported quality measures..  160:943-950.e1-5. 2010
• Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study..  160:371-379.e2. 2010
• Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study..  160:464-70. 2010
• Beyond insurance coverage: usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003-2006 National Health and Nutrition Examination Survey..  160:115-21. 2010
• ST-elevation myocardial infarction patients can be enrolled in randomized trials before emergent coronary intervention without sacrificing door-to-balloon time..  159:-. 2010
• Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies..  159:864-70. 2010
• Rationale and design of the Duke Electrophysiology Genetic and Genomic Studies (EPGEN) biorepository..  158:719-25. 2009
• Baseline differences in the HF-ACTION trial by sex..  158:S16-23. 2009
• Myocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial..  158:S53-63. 2009
• N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study..  158:S37-44. 2009
• New York Heart Association functional class predicts exercise parameters in the current era..  158:S24-30. 2009
• Outcomes, health policy, and managed care: relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure..  158:S64-71. 2009
• Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: the HF-ACTION study..  158:S45-52. 2009
• Relationship of age and exercise performance in patients with heart failure: the HF-ACTION study..  158:S6-S15. 2009
• Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction..  158:S72-7. 2009
• The relationship between body mass index and cardiopulmonary exercise testing in chronic systolic heart failure..  158:S31-6. 2009
• Understanding heart failure through the HF-ACTION baseline characteristics..  158:S1-5. 2009
• Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey..  157:702-8.e1. 2009
• Optimizing cardiology capacity to reduce emergency department boarding: a systems engineering approach..  156:1202-9. 2008
• Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial..  156:528-536, 536.e1-5. 2008
• The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study..  155:823-8. 2008
• Genetic association studies; the good, the bad, and the ugly..  154:610-2. 2007
• Dietary carbohydrate intake and high-sensitivity C-reactive protein in at-risk women and men..  154:962-8. 2007
• Effect of exercise training on ventricular function, dyssynchrony, resting myocardial perfusion, and clinical outcomes in patients with heart failure: a nuclear ancillary study of Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION); design and rationale..  154:46-53. 2007
• Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale..  153:201-11. 2007
• Cardiac Certificate of Need regulations and the availability and use of revascularization services..  154:767-75. 2007
• Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery..  152:1028-34. 2006
• Response of high-sensitivity C-reactive protein to exercise training in an at-risk population..  152:793-800. 2006
• Nutrition as a contributor and treatment option for overweight and obesity..  151:628-32. 2006
• Obesity and physical activity: a review..  151:598-603. 2006
• Smoking cessation in patients with coronary artery disease..  149:565-72. 2005
• Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS)..  149:512-9. 2005
• Underlying risk factors incrementally add to the standard risk estimate in detecting subclinical atherosclerosis in low- and intermediate-risk middle-aged asymptomatic individuals..  148:871-7. 2004
• Electron beam CT versus helical CT scans for assessing coronary calcification: current utility and future directions..  146:969-77. 2003
• Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study..  146:839-47. 2003
• Assessing risk for coronary heart disease: beyond Framingham..  146:572-80. 2003
• Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure..  146:250-7. 2003
• Differential effects of exercise training in men and women with chronic heart failure..  145:912-8. 2003
• Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study..  145:602-13. 2003
• Angiotensin-converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: identifying the guideposts for navigating the genetics landscape..  144:747-9. 2002
• The relative importance of left atrial function versus dimension in predicting atrial fibrillation after coronary artery bypass graft surgery..  143:181-6. 2002
• Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction..  142:160-6. 2001
• Genetic approaches for the investigation of genes associated with coronary heart disease..  140:S27-35. 2000
• Genetics of coronary heart disease: current knowledge and research principles..  140:S11-26. 2000
• Ventricular dysrhythmias in patients undergoing coronary artery bypass graft surgery: incidence, characteristics, and prognostic importance. Study of Perioperative Ischemia (SPI) Research Group..  123:73-81. 1992
• Trends in cardiorespiratory fitness: The evolution of exercise treadmill testing at a single Academic Medical Center from 1970 to 2012. 2019

Identity

International Standard Serial Number (ISSN)

• 0002-8703
• 1097-6744